Table 1.
Name | Regulation/function | Phosphoinositide effects |
---|---|---|
TRPM1 | Mutation causes night blindness in humans |
No phosphoinositide effect reported yet |
TRPM2 | Activated by ADP ribose | Poly-lysine inhibits, and PI(4,5)P2 re-activates in excised patches (Toth and Csanady, 2012) |
TRPM3 | Heat, pregnenolon sulphate | No phosphoinositide effect reported yet |
TRPM4 | Intracellular Ca2+ activates, non-selective Ca2+ impermeable cation channel |
PI(4,5)P2 activates in excised patches (Zhang et al., 2005; Nilius et al., 2006) |
TRPM5 | Intracellular Ca2+ activates non-selective Ca2+ impermeable cation channel |
PI(4,5)P2 activates in excised patches (Liu and Liman, 2003) |
TRPM6 | Mg2+ transporter, mutation causes human disease |
PI(4,5)P2 activates in excised patches, rapamycin-inducible 5 phosphatase and ciVSP inhibits (Xie et al., 2011) |
TRPM7 | cAMP, shear stress, plays important roles in development |
PI(4,5)P2 activates in excised patches, activation of PLC inhibits (Runnels et al., 2002). PI(4,5)P2 is needed for the activity of the cardiac magnesium- inhibited TRPM7-like channels (Gwanyanya et al., 2006). Role of PLC mediated inhibition is challenged (Takezawa et al., 2004; Langeslag et al., 2007) |
TRPM8 | Cold, Menthol | PI(4,5)P2 activates in excised patches (Liu and Qin, 2005; Rohacs et al., 2005; Yudin et al., 2011) PI(4,5)P2 depletion inhibits (rapamycin, ciVSP), plays a role in desensitization (Rohacs et al., 2005; Daniels et al., 2009; Yudin et al., 2011) PI(4,5)P2 but not PI(4)P activates in planar lipid bilayers (Zakharian et al., 2009; Zakharian et al., 2010) PI(4,5)P2 regulates temperature threshold (Fujita et al., 2013) |